Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
When screening various isoquinolinesulfonamide compounds which we synthesized,
CKI
-7, N-(2-amino-ethyl)-
5-chloroisoquinoline
-8-sulfonamide, was found to have a potent inhibitory action against
casein kinase I
and a much weaker effect on
casein kinase II
and other protein kinases. Kinetic analysis indicated that
CKI
-7 inhibited
casein kinase I
competitively with respect to ATP and that the Ki values were 8.5 microM for
casein kinase I
and 70 microM for
casein kinase II
. An affinity chromatography absorbent was synthesized by coupling
CKI
-8 (1-(
5-chloroisoquinoline
-8-sulfonyl], a derivative of
CKI
-7, to cyanogen bromide-activated Sepharose 4B. Partially purified
casein kinase I
from bovine testis was subjected to affinity chromatography. Analysis of the purified
casein kinase I
by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate revealed a single band with molecular weight 37,000. These newly synthesized compounds,
CKI
-7 and
CKI
-8, should serve as useful tools for elucidating the biological significance of
casein kinase I
-mediated reactions.
...
PMID:A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis. 292 75
Three cDNA clones encoding isoforms of
casein kinase I
(
CKI
) were isolated from Arabidopsis thaliana. One full-length clone, designated CKI1, contained an open reading frame of 1371 bp encoding a protein of 51,949 D with an isoelectric point of 9.7. In addition to the highly conserved catalytic domain (of about 300 amino acids), the Arabidopsis
CKI
isoforms contain 150 to 180 amino acid carboxyl-terminal extensions, which show among themselves a lower level of sequence conservation. These extensions do not show any sequence similarity to nonplant
CKI
isoforms, such as rat testis
CKI
delta, which is their closest isolated homolog, or to yeast
CKI
isoforms. Three additional isoforms of Arabidopsis
CKI
were found in the data bases of expressed sequence tags and/or were isolated serendipitously in nonspecific screening procedures by others. One of them also shows a carboxyl-terminal extension, but of only 80 amino acids. Casein kinase activity was detected in the soluble fraction of Escherichia coli strains expressing the CKI1 protein. This activity showed the crucial properties of
CKI
, including the ability to phosphorylate the D4 peptide, a specific substrate of
CKI
, and inhibition by N-(2-aminoethyl)-
5-chloroisoquinoline
-8-sulfonamide, a specific
CKI
inhibitor. Like several recombinant
CKI
isoforms from yeast, CKI1 was able to phosphorylate tyrosine-containing acidic polymers.
...
PMID:Multiple isoforms of Arabidopsis casein kinase I combine conserved catalytic domains with variable carboxyl-terminal extensions. 748 Mar 53
A soluble fragment of YCK2, a
casein kinase
-1 isoform from Saccharomyces cerevisiae, has been purified and characterized in vitro. The procedure enriches enzyme activity to a final specific activity of 4.7 mumol min-1 mg-1 (when assayed with casein as substrate). Structural analysis reveals that the preparation arises from N-terminal modification and C-terminal proteolysis of the initially synthesized 546-residue protein, consisting of residues 2-495 +/- 1. Kinetic analysis demonstrates that YCK2 is similar to
casein kinase
-1 isolated from other organisms in its inability to use GTP as nucleotide substrate, in its sensitivity to heparin and ribofuranosyl-benzimidazole inhibitors, and in its peptide substrate selectivity. The enzyme is unusual, however, in that it is insensitive to the potent mammalian
casein kinase
-1 inhibitor N-(2-aminoethyl)-
5-chloroisoquinoline
-8-sulfonamide.
...
PMID:Isolation and properties of YCK2, a Saccharomyces cerevisiae homolog of casein kinase-1. 834 55
Neurofilament (NF)-enriched preparations from bovine spinal cord contain regulator-independent kinase activities that phosphorylate NF subunits as well as alpha-casein.
CKI
-7 (N-2-amino ethyl,
5-chloroisoquinoline
, 8-sulfonamide), a specific inhibitor of
casein kinase I
(
CKI
), inhibits the phosphorylation of NF subunits in the neurofilament preparation. This inhibition occurs at a concentration range identical to concentrations where
CKI
-7 inhibits rabbit reticulocyte
CKI
phosphorylation of alpha-casein. Heparin, a specific inhibitor of
casein kinase II
(
CKII
), produced only 20% inhibition of 32P incorporation into NF subunits, and only at concentrations 5 to 10-fold higher than those required to inhibit
CKII
from reticulocytes.
CKI
from rabbit reticulocytes phosphorylated all three NF subunits (NF-H, NF-M and NF-L). Comparison of the tryptic phosphopeptide maps of NF-M, phosphorylated by the NF-associated kinase and
CKI
, indicates that the
casein kinase I
phosphorylates many of the peptides phosphorylated by the NF-associated kinase and this phosphorylation occurs at the carboxy terminal tail domain of the NF-M subunit. These studies suggest that the major independent kinase activity associated with NFs is
CKI
.
...
PMID:Bovine neurofilament-enriched preparations contain kinase activity similar to casein kinase I--neurofilament phosphorylation by casein kinase I (CKI). 838 62
A large family of isoquinoline sulfonamide compounds inhibits protein kinases by competing with adenosine triphosphates(ATP), yet interferes little with the activity of other ATP-using enzymes such as ATPases and adenylate cyclases. One such compound, N-(2-aminoethyl)-
5-chloroisoquinoline
-8-sulfonamide (CK17), is selective for
casein kinase
-1 isolated from a variety of sources. Here we report the crystal structure of the catalytic domain of Schizosaccharomyces pombe
casein kinase
-1 complexed with CK17, refined to a crystallographic R-factor of 17.8% at 2.5 angstrom resolution. The structure provides new insights into the mechanism of the ATP-competing inhibition and the origin of their selectivity toward different protein kinases. Selectivity for protein kinases versus other enzymes is achieved by hydrophobic contacts and the hydrogen bond with isoquinoline ring. We propose that the hydrogen bond involving the ring nitrogen-2 atom of the isoquinoline must be preserved, but that the ring can flip depending on the chemical substituents at ring positions 5 and 8. Selectivity for individual members of the
protein kinase
family is achieved primarily by interactions with these substituents.
...
PMID:Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors. 869 11
Nck is a 47-kDa cytosolic protein devoid of intrinsic catalytic activity and consisting of Src homology 2 and 3 (SH2 and SH3) domains organized as follows: SH3-SH3-SH3-SH2. Nck is believed to act as an adaptor protein mediating signal transduction initiated by receptor tyrosine kinases (RTKs). Through its SH2 domain, Nck recognizes a specific phosphotyrosine residue on RTKs or on protein substrates of RTKs like insulin receptor substrate-1, the major substrate of the insulin receptor, and through its SH3 domains it interacts with poorly characterized effector molecules. To identify novel proteins that might interact with Nck, we have used the amino-terminal segment of Nck encompassing its three SH3 domains in the yeast two-hybrid system. Among the polypeptides that associate with Nck, we have identified the gamma2 isoform of the serine/threonine
casein kinase I
(
CKI
-gamma2). In transformed rat hepatocytes overexpressing the insulin receptor (HTC-IR cells),
serine/threonine protein kinase
activity coimmunoprecipitates with Nck, an interaction mediated mainly by the third SH3 domain of Nck. This kinase activity is not apparently modulated by insulin, nor is it sensitive to staurosporine or heparin, and it does not use GTP as a phosphate donor. However the kinase activity coimmunoprecipitated with Nck is completely abolished by N-(2-aminoethyl)-
5-chloroisoquinoline
-8-sulfonamide, a specific inhibitor of
casein kinase I
. In an in vitro renaturation gel kinase assay, a
protein kinase
of 70-75 kDa was detected associated with the SH3 domains of Nck. Far Western analysis demonstrated that the SH3 domains of Nck bound directly to a cytosolic protein of 70-75 kDa. A rabbit polyclonal antibody raised against the C-terminal region of
CKI
-gamma2
protein kinase
immunoprecipitated a single specific protein of 70-75 kDa from HTC-IR cell lysates and detected
CKI
-gamma2 among the proteins coimmunoprecipitated with Nck. These results support an in vivo interaction between Nck and
CKI
-gamma2 and suggest that
CKI
-gamma2 could be involved in signaling pathways downstream of RTKs.
...
PMID:A casein kinase I activity is constitutively associated with Nck. 900 5
The lens fiber cell-specific gap junction protein connexin49 is a substrate for a membrane-associated Ser/Thr protein kinase that can be extracted from lens cell membranes by 0.6 M KCl. However, the identity of this
protein kinase
has not been defined. In this report, evidence is presented indicating that it is
casein kinase I
. Thus, connexin49 was shown to be a substrate for purified
casein kinase I
but not for
casein kinase II
; the endogenous connexin49
protein kinase
activity extracted from lens membranes with KCl was inhibited by the
casein kinase I
-specific inhibitor, N-(2-aminoethyl)-
5-chloroisoquinoline
-8-sulfonamide (
CKI
-7); the connexin49
protein kinase
activity in the lens membrane KCl extract, which could be partially purified by gel filtration and affinity purification with a casein-Sepharose 4B column, copurified with
casein kinase
activity; phosphopeptide analysis showed that
casein kinase I
and the connexin49
protein kinase
activity in the lens membrane KCl extract probably share the same phosphorylation sites in connexin49. Reverse transcription-PCR using total ovine lens RNA and
casein kinase I
isoform-specific oligonucleotide primers resulted in the amplification of cDNAs encoding casein kinase I-alpha and -gamma, while an in-gel
casein kinase
assay indicated
casein kinase
activity in the lens membrane KCl extract was associated with a major 39.2-kDa species, which is consistent with the 36 to 40-kDa size of casein kinase I-alpha in other animal species. These results demonstrate that the
protein kinase
activity present in the lens membrane 0.6 M KCl extract that catalyzes the phosphorylation of connexin49 is
casein kinase I
, probably the alpha isoform.
...
PMID:Endogenous casein kinase I catalyzes the phosphorylation of the lens fiber cell connexin49. 1042 14
Two
protein kinase
activities that use casein as a substrate, Q-I and Q-II, were identified in the epimastigote stage of Trypanosoma cruzi upon chromatography on Q-Sepharose. Q-I was purified further through concanavalin A-sepharose (Q-I*) to remove any trace of the contaminating protease cruzipain. The optimal activity for Q-I* was obtained at pH 8.0, 25 degreesC, 5 mM MgCl(2) and 75 mM NaCl. The size and pI of Q-I* were determined to be 33-36 kDa and 9.6, respectively. When two selective peptide substrates for casein kinases (CKs) (P1: RRKDLHDDEEDEAMSITA for CK1 and P2: RRRADDSDDDDD for CK2) were used, Q-I* was shown to specifically phosphorylate P1. Kinetic studies showed that Q-I* has a K(m) of 5.3 +/- 0.34 mg/ml for casein, 157.6 +/- 5.3 microM for P1 and 35.9 +/- 3.9 microM for ATP. The enzyme was inhibited by N-(2-amino-ethyl)-
5-chloroisoquinoline
-8-sulfonamide (
CKI
-7) or 1-(
5-chloroisoquinoline
-8-sulfonyl) (
CKI
-8), two inactivators of mammalian CKs.
CKI
-7 behaved as a competitive inhibitor with respect to ATP, with a K(I) of 75-100 microM. Treatment with high concentrations of polylysine or heparin also resulted in a significant inhibition of Q-I*. Two well-known activators of mammalian CKs, spermine and spermidine, were also tested. Spermine and spermidine activated Q-I* in a dose-dependent manner. Based on the following characteristics: (1) the ionic strength required for elution from anion-exchange resins; (2) its molecular size and monomeric structure; (3) pI; (4) high level of specificity for P1; (5) inactivation by
CKI
-7 and
CKI
-8; and (6) insensitivity to GTP and low concentrations of heparin, we conclude that Q-I* belongs to the CK1 family of protein kinases.
...
PMID:Biochemical and enzymatic characterization of a partially purified casein kinase-1 like activity from Trypanosoma cruzi. 1188 Feb 25
A
protein kinase
activity, which uses casein as a substrate, has been purified to homogeneity from the epimastigote stage of Trypanosoma cruzi, by sequential chromatography on Q sepharose, heparin sepharose, phenyl sepharose, and alpha-casein agarose. An apparent molecular weight of 36,000 was estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Gel filtration chromatography and sedimentation analyses demonstrated that the purified native enzyme is a monomer with a sedimentation coefficient of 2.9 S. The hydrodynamic parameters indicated that the shape of the protein is globular with a frictional ratio f/f(o) = 1.36 and a Stokes radius of 27.7 A. When two selective peptide substrates for protein kinases CK1 and CK2 were used (RRKDLHDDEEDEAM. SITA and RRRADDSDDDDD, respectively), the purified kinase was shown to predominantly phosphorylate the CK1-specific peptide. Additionally, the enzyme was inhibited by N-(2-amino-ethyl)-
5-chloroisoquinoline
-8-sulfonamide, a specific inactivator of CK1s from mammals. Based on these results, we concluded that the purified kinase corresponds to a parasite CK1.
...
PMID:Protein kinase CK1 from Trypanosoma cruzi. 1470 93